Results 171 to 180 of about 778,919 (247)

STING Agonist-Loaded Physalis Mottle Virus-like Particles as a Potent Prophylactic for Metastatic Melanoma. [PDF]

ACS Appl Mater Interfaces
Simms A, Affonso de Oliveira JF, Steinmetz NF.   +2 more
europepmc   +1 more source

Disassembly of Virus-Like Particles and the Stabilizing Role of the Nucleic Acid Cargo. [PDF]

J Phys Chem B
Paine AW, Hagan MF, Manoharan VN.
europepmc   +1 more source

Improved mRNA-based RSV vaccine with PreF forming enveloped virus-like particles. [PDF]

NPJ Vaccines
Chai P, Shi Y, Li X, Yang M, Liu X, Liu M, Yu J, Yin X, Li D, Li K, Kong X, Zhang Q, Wang H, Sun X, Li J, Li L, Li D, Pang L, Lu X, Duan Z.   +19 more
europepmc   +1 more source

Self-assembly and immunogenicity of virus-like particles from goose astrovirus 1 structural protein following proteolytic maturation in a baculovirus system. [PDF]

Poult Sci
Wang A, Wu Z, Liu L, Zhou Q, Cheng Y, Jia W, Lu H, Xie J, Zhu S.   +8 more
europepmc   +1 more source

Platform Process for an Autonomous Production of Virus-like Particles. [PDF]

ACS Omega
Baukmann S, Hengelbrock A, Katsoutas K, Stitz J, Schmidt A, Strube J.   +5 more
europepmc   +1 more source

Engineering virus-like particles for safe and versatile modeling of SARS-CoV-2 host interaction and immune escape. [PDF]

Commun Biol
Ma L, Lin Y, Ma S, Chen K, Lin Y.
europepmc   +1 more source

Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale. [PDF]

Biotechnol Bioeng
Edeling MA, Earnest L, Carrera Montoya J, Yap AHY, Mumford J, Roberts J, Wong CY, Hans D, Grima J, Bisset N, Bodle J, Rockman S, Torresi J.   +12 more
europepmc   +1 more source

Characterization of full-length and cytoplasmic tail-truncated envelope glycoproteins incorporated into human immunodeficiency virus (HIV-1) virions and virus-like particles. [PDF]

J Virol
Anang S, Zhang S, Ennis A, Ding H, Deshpande A, Nguyen HT, Kappes JC, Sodroski JG.   +7 more
europepmc   +1 more source

Persistent Green Luminescence in Nanoparticles Functionalized with SARS-CoV-2 Spike Proteins: Virus-Like Particles Showing Active Targeting toward Selected Cells. [PDF]

ACS Appl Bio Mater
Kuich P, Bazylińska U, Kulbacka J, Boiko V, Hreniak D, Jewgiński M, Nyk M, Wawrzyńczyk D.   +7 more
europepmc   +1 more source